STEVEN POERTNER: Open Payments
NPI 1467834143 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 60 payments from 16 companies in 2025. Trend: 2023 $163 · 2024 $856 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $240 |
| Amgen Inc. | 17 | $231 |
| Lilly USA, LLC | 4 | $75 |
| Exact Sciences Corporation | 4 | $75 |
| ABBVIE INC. | 3 | $66 |
| Astellas Pharma US Inc | 3 | $61 |
| Intra-Sana Laboratories | 3 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $39 |
Products named: Wegovy, OTEZLA, KRYSTEXXA, VRAYLAR, Veozah, The Cologuard Plus Collection Kit, MOUNJARO, RELTONE 200 MG.
Industry payments across NV — which companies pay providers there.
